SIGNALING MOLECULES: THE PLACE AND THE ROLE IN PERSONALIZED DIAGNOSTICS, TREATMENT AND PREVENTION OF SOCIALLY SIGNIFICANT DISEASES
This review is devoted to availability of investigation of expression of signaling molecules in personalized and predictive medicine. As exemplified in cardio-vascular pathology (hypertonic disease, myocardial infarction), Alzheimer’s disease and chronic obstructive pulmonary disease the high-potency of molecular methods for examination and identification of predisposition, differential diagnosis, prognosis and the choice of optimal therapeutic approach to social significant diseases has been shown.